Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Hedge Fund:254’

Copyright: nexusplexus / 123RF Stock Photo

13D Filing: OrbiMed Advisors and Adaptimmune Therapeutics PLC – ADR (ADAP)

Adaptimmune Therapeutics PLC – ADR (NASDAQ:ADAP): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors......(read more)
easiest countries to get oxycodone prescribed

13D Filing: OrbiMed Advisors and Corvus Pharmaceuticals Inc (CRVS)

Corvus Pharmaceuticals Inc (NASDAQ:CRVS): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest......(read more)
Countries with the Lowest Cancer Rates in the World in 2018

13D Filing: OrbiMed Advisors and Viewray Inc. (VRAY)

Viewray Inc. (NASDAQ:VRAY): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest holdings and......(read more)
10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

13D Filing: OrbiMed Advisors and Pieris Pharmaceuticals Inc. (PIRS)

Pieris Pharmaceuticals Inc. (NYSE:PIRS): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest......(read more)
Medical treatments, advanced medical equipment, medical devices

13D Filing: OrbiMed Advisors and Nabriva Therapeutics PLC – ADR (NBRV)

Nabriva Therapeutics PLC – ADR (NASDAQ:NBRV): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’......(read more)
pharmacist, medical, retail, worker, team, young, staff, lab, chemistry, business, drug, chemist, adult, teamwork, drugstore, service,

13D Filing: OrbiMed Advisors and Pieris Pharmaceuticals Inc. (PIRS)

Pieris Pharmaceuticals Inc. (NYSE:PIRS): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest......(read more)
Pressmaster/Shutterstock.com

13D Filing: OrbiMed Advisors and Alpine Immune Sciences Inc. (ALPN)

Alpine Immune Sciences Inc. (NASDAQ:ALPN): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest......(read more)
pharmacist, medical, retail, worker, team, young, staff, lab, chemistry, business, drug, chemist, adult, teamwork, drugstore, service,

13D Filing: OrbiMed Advisors and Clementia Pharmaceuticals Inc (CMTA)

Clementia Pharmaceuticals Inc (NASDAQ:CMTA): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest......(read more)
Doctor Specialties with Best Lifestyle

13D Filing: OrbiMed Advisors and Xtant Medical Holdings Inc. (XTNT)

Xtant Medical Holdings Inc. (OTCMKTS:XTNT): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest......(read more)
10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

13D Filing: OrbiMed Advisors and Pieris Pharmaceuticals Inc. (PIRS)

Pieris Pharmaceuticals Inc. (NYSE:PIRS): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest......(read more)
pharmacist, medical, retail, worker, team, young, staff, lab, chemistry, business, drug, chemist, adult, teamwork, drugstore, service,

13D Filing: OrbiMed Advisors and Scpharmaceuticals Inc (SCPH)

Scpharmaceuticals Inc (NASDAQ:SCPH): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest holdings......(read more)
one photo/Shutterstock.com

13D Filing: OrbiMed Advisors and Arsanis Inc (ASNS)

Arsanis Inc (NASDAQ:ASNS): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest holdings and filings......(read more)
Doctor Specialties with Best Lifestyle

13D Filing: OrbiMed Advisors and Loxo Oncology Inc. (LOXO)

Loxo Oncology Inc. (NASDAQ:LOXO): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest holdings......(read more)
Easiest Md/PhD Programs to Get Into

13D Filing: OrbiMed Advisors and Intellia Therapeutics Inc (NTLA)

Intellia Therapeutics Inc (NASDAQ:NTLA): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest......(read more)
Medical devices, medical equipment

13D Filing: OrbiMed Advisors and Viewray Inc (VRAY)

Viewray Inc (NASDAQ:VRAY): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest holdings and filings......(read more)
10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

13D Filing: OrbiMed Advisors and Rhythm Pharmaceuticals Inc (RYTM)

Rhythm Pharmaceuticals Inc (NASDAQ:RYTM): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest......(read more)
Pressmaster/Shutterstock.com

13D Filing: OrbiMed Advisors and Roka Bioscience Inc. (ROKA)

Roka Bioscience Inc. (NASDAQ:ROKA): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest holdings......(read more)
15 Biggest US Government Cover Ups of All Time

13D Filing: OrbiMed Advisors and Roka Bioscience Inc. (ROKA)

Roka Bioscience Inc. (NASDAQ:ROKA): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest holdings......(read more)
Easiest Md/PhD Programs to Get Into

13D Filing: OrbiMed Advisors and Roka Bioscience Inc. (ROKA)

Roka Bioscience Inc. (ROKA): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest holdings and......(read more)
Top 12 Anesthesiology Residency Programs in 2018

13D Filing: OrbiMed Advisors and Synlogic Inc. (SYBX)

Synlogic Inc. (NASDAQ:SYBX): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest holdings and......(read more)
easiest countries to get oxycodone prescribed

13D Filing: OrbiMed Advisors and Clementia Pharmaceuticals Inc (CMTA)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 12 – SEC Filing UNITED STATESSECURITIES AND EXCHANGE......(read more)
Samuel Isaly - Orbimed Advisors

13D Filing: OrbiMed Advisors and Roka Bioscience Inc. (ROKA)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 11 – SEC Filing   UNITED STATES SECURITIES AND EXCHANGE......(read more)
Pressmaster/Shutterstock.com

13D Filing: OrbiMed Advisors and Selecta Biosciences Inc (SELB)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 12 – SEC Filing UNITED STATESSECURITIES AND EXCHANGE......(read more)
Samuel Isaly - Orbimed Advisors

13D Filing: OrbiMed Advisors and Clementia Pharmaceuticals Inc (CMTA)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 14 – SEC Filing UNITED STATESSECURITIES AND EXCHANGE......(read more)
Samuel Isaly - Orbimed Advisors

13D Filing: OrbiMed Advisors and Viewray Inc (VRAY)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 12 – SEC Filing UNITED STATESSECURITIES AND EXCHANGE......(read more)
15 Biggest US Government Cover Ups of All Time

13D Filing: OrbiMed Advisors and Alpine Immune Sciences Inc. (ALPN)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 10 – SEC Filing UNITED STATESSECURITIES AND EXCHANGE......(read more)
Samuel Isaly Orbimed Advisors

13D Filing: OrbiMed Advisors and Otonomy Inc. (OTIC)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 11 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......(read more)
Samuel Isaly - Orbimed Advisors

13D Filing: OrbiMed Advisors and Ascendis Pharma A/S (ASND)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 14 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......(read more)
Samuel Isaly Orbimed Advisors

13D Filing: OrbiMed Advisors and Verona Pharma PLC (VRNA)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 12 – SEC Filing UNITED STATESSECURITIES AND EXCHANGE......(read more)
Samuel Isaly - Orbimed Advisors

13D Filing: OrbiMed Advisors and Steadymed Ltd. (STDY)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 15 – SEC Filing   UNITED STATES SECURITIES AND EXCHANGE......(read more)
Samuel Isaly - Orbimed Advisors

13D Filing: OrbiMed Advisors and Viewray Inc. (VRAY)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 12 – SEC Filing   UNITED STATESSECURITIES AND EXCHANGE......(read more)
Can hedge funds beat the market

140 Biggest and Most Famous Activist Hedge Funds

Some of the names we are going to show on this top 140 biggest and most famous activist hedge funds list are the investors that keep certain executives......(read more)
Samuel Isaly Orbimed Advisors

Affimed N.V. (AFMD): OrbiMed Advisors Cuts Its Position

A freshly-amended 13D filing with the US SEC showed that Sam Isaly’s OrbiMed Advisors has sold some of its shares of Affimed N.V. (NASDAQ:AFMD), hence......(read more)
Samuel Isaly - Orbimed Advisors

Steadymed Ltd. (STDY): OrbiMed Advisors Reports Large New Stake

Sam Isaly’s OrbiMed Advisors recently filed a Form 13D with the Securities and Exchange Commission in which reported the acquisition of 3.07 million......(read more)
Samuel Isaly Orbimed Advisors

Loxo Oncology Inc. (LOXO): OrbiMed Advisors Reports Percentage of Ownership Change

Samuel Isaly’s OrbiMed Advisors recently filed a 13D filing with the SEC in which it reported owning 2.18 million common shares of Loxo Oncology Inc......(read more)
Samuel Isaly - Orbimed Advisors

Selecta Biosciences Inc (SELB): OrbiMed Advisors Reports New Stake

Samuel Isaly’s Orbimed Advisors recently filed a Form 13D with the Securities and Exchange Commission, in which it reported a new stake in Selecta Biosciences......(read more)
Samuel Isaly Orbimed Advisors

Healthcare Investor Sam Isaly Was Wrong About These 2 Stocks; Makes a Lot of Money on Freshly-Acquired Insurer

OrbiMed Advisors LLC is the world’s largest healthcare-focused investment firm, managing roughly $15 billion in net assets under management. The healthcare......(read more)
Samuel Isaly Orbimed Advisors

Affimed NV (AFMD): Samuel Isaly Unloads Shares of Sinking Stock

Affimed NV (NASDAQ:AFMD) is the subject of a 13D filing from Samuel Isaly‘s OrbiMed Advisors, which shows that the investment firm has sold off......(read more)
Felix Baker - Baker Bros.

A Look At Three Activist Moves By Several Elite Hedge Funds

According to the Schulte, Roth & Zabel’s Activist Investing 2015 Annual Review, 344 companies were targeted by activist investors in 2014, as compared......(read more)
Barry Rosenstein JANA PARTNERS

Two Healthcare-Focused Funds Buy More Shares Of 2 Promising Companies, While Activist Cashes Out Of IT Company

You don’t necessarily need millions of dollars to invest like an activist investor such as Carl Icahn or Bill Ackman. Extensive research has concluded......(read more)
HIGHBRIDGE CAPITAL MANAGEMENT

Hedge Fund Sentiment Has This to Say About These Moves on 3 Healthcare Stocks

It is easy to imagine that hedge funds would not reveal their equity positions if it were not for reporting requirements enforced by the Securities......(read more)
Samuel Isaly Orbimed Advisors

OrbiMed Advisors Piles On This Biotech; Should You Follow This Healthcare-Focused Firm?

It is commonly known that most hedge fund investors reveal their positions through 13F quarterly filings, but 13D filings tend to provide more insights......(read more)
Hedge-Fund-Managers-Group-+-Logo--500x250

28 Hedge Funds That Are Getting Destroyed By These 25 Stocks

Everybody is talking about Bill Ackman’s nearly $2 billion losses in Valeant (VRX). Valeant isn’t the only stock that is costing hedge funds......(read more)
Samuel Isaly Orbimed Advisors

These Two Healthcare Stocks Receive A Vote Of Confidence From Elite Hedge Fund Managers

As U.S equities have plummeted on global-growth worries, confident hedge funds and other investors have started piling up more shares of companies that......(read more)
Samuel Isaly - Orbimed Advisors

Samuel Isaly’s New Healthcare Positions: Community Health Systems (CYH), Glaukos Corp (GKOS), More

Samuel Isaly’s OrbiMed Advisors is a healthcare fund with $15 billion worth of assets under management. The investment advisory firm has experience......(read more)
Samuel Isaly - Orbimed Advisors

Aisling Capital and OrbiMed Advisors See Value in This Canadian Pharmaceutical Company, Disclosing New Positions

Dennis Purcell’s Aisling Capital and Samuel Isaly’s OrbiMed Advisors have initiated new positions in Cynapsus Therapeutics Inc (NASDAQ:CYNA). In new......(read more)
Samuel Isaly Orbimed Advisors

Samuel Isaly’s OrbiMed Advisors Discloses Large Stake in Glaukos Corp (GKOS) After Its IPO

Glaukos Corp (NYSE:GKOS) is an $870 million developer of products for the treatment of glaucoma, which conducted its IPO last week with 6.90 million shares......(read more)
Jacob Gottlieb - Visium Asset Management

Esperion Therapeutics Inc (ESPR), Intercept Pharmaceuticals Inc (ICPT): Visium and OrbiMed’s Recent Activity in Biotech

Stocks in the biotechnology industry have been very active as of late, with companies’ shares registering significant gains. The industry jumped......(read more)
Samuel Isaly Orbimed Advisors

Healthcare Hedge Fund Orbimed’s Top Picks and New Move

According to a Schedule 13D form filed yesterday with the Securities and Exchange Commission, Samuel Islay‘s Orbimed Advisors has slashed its stake......(read more)
Sientra

Sientra Inc (SIEN), TESARO Inc (TSRO) and Clovis Oncology Inc (CLVS): Orbimed’s Top New Picks

Samuel Islay‘s Orbimed Advisors has revealed its equity portfolio as of end of 2014, in a recent filing with the Securities and Exchange Commission......(read more)